Sameh Saber

3.1k total citations
118 papers, 2.1k citations indexed

About

Sameh Saber is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Sameh Saber has authored 118 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 19 papers in Hepatology and 18 papers in Epidemiology. Recurrent topics in Sameh Saber's work include Inflammasome and immune disorders (13 papers), Liver physiology and pathology (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Sameh Saber is often cited by papers focused on Inflammasome and immune disorders (13 papers), Liver physiology and pathology (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Sameh Saber collaborates with scholars based in Egypt, Saudi Arabia and Romania. Sameh Saber's co-authors include Eman El‐Ahwany, Galal Yahya, Mahmoud E. Youssef, Simona Cavalu, Walied Abdo, Noha A. Amin, Amal M. H. Ghanim, Ahmed Shata, Mustafa Ahmed Abdel‐Reheim and Ahmed A.E. Mourad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Sameh Saber

108 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameh Saber Egypt 31 969 313 216 211 211 118 2.1k
Xinyu Chen China 20 727 0.8× 183 0.6× 233 1.1× 219 1.0× 243 1.2× 122 2.0k
Yuan‐Yen Chang Taiwan 29 746 0.8× 303 1.0× 158 0.7× 136 0.6× 150 0.7× 81 2.0k
Hui Chen China 25 1.1k 1.2× 367 1.2× 276 1.3× 170 0.8× 172 0.8× 125 2.4k
Yao Wang China 27 1.0k 1.1× 343 1.1× 235 1.1× 148 0.7× 302 1.4× 87 2.1k
Yan Yang China 31 1.2k 1.3× 427 1.4× 335 1.6× 207 1.0× 287 1.4× 96 2.4k
Lihua Zhang China 24 923 1.0× 380 1.2× 242 1.1× 245 1.2× 227 1.1× 128 2.2k
Huihui Xu China 31 1.5k 1.6× 407 1.3× 263 1.2× 196 0.9× 323 1.5× 92 2.4k
Lei Gao China 21 647 0.7× 168 0.5× 269 1.2× 209 1.0× 180 0.9× 123 1.5k
Yulan Liu China 20 1.3k 1.3× 627 2.0× 201 0.9× 370 1.8× 391 1.9× 62 3.0k

Countries citing papers authored by Sameh Saber

Since Specialization
Citations

This map shows the geographic impact of Sameh Saber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameh Saber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameh Saber more than expected).

Fields of papers citing papers by Sameh Saber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameh Saber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameh Saber. The network helps show where Sameh Saber may publish in the future.

Co-authorship network of co-authors of Sameh Saber

This figure shows the co-authorship network connecting the top 25 collaborators of Sameh Saber. A scholar is included among the top collaborators of Sameh Saber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameh Saber. Sameh Saber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamad, Rabab S., Elsayed A. Elmorsy, Mahmoud A. Abdelaziz, et al.. (2025). Sirtuin 6-driven ASC deacetylation confers hepatoprotection: A promising approach to inflammasome inhibition in experimental NASH. European Journal of Pharmacology. 1006. 178202–178202. 1 indexed citations
3.
Saber, Sameh, Zubida M. Al‐Majdoub, Rabab S. Hamad, et al.. (2025). Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitis. European Journal of Pharmaceutical Sciences. 209. 107100–107100. 3 indexed citations
4.
Hamad, Rabab S., Sameh Saber, Amel Ahmed, et al.. (2025). Dual-sensitive gelatin-coated chitosan microparticles for targeted semaglutide pulmonary delivery: a novel approach to enhancing anti-inflammatory and anti-fibrotic effects. International Immunopharmacology. 165. 115480–115480.
5.
Elmorsy, Elsayed A., Manal Mohamed Kamal, Rabab S. Hamad, et al.. (2025). Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6. European Journal of Pharmaceutical Sciences. 214. 107302–107302.
6.
Cavalu, Simona, Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, et al.. (2025). Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions. International Journal of Nanomedicine. Volume 20. 741–770. 7 indexed citations
7.
Shehatou, George S.G., et al.. (2024). Diltiazem mitigates acute liver injury by targeting NFκB-TXNIP/NLRP3 axis in Rats: New insights beyond calcium channel blockade. International Immunopharmacology. 143(Pt 2). 113460–113460. 2 indexed citations
8.
Abdelhamid, A. M., Sameh Saber, Rabab S. Hamad, et al.. (2024). STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide. Frontiers in Pharmacology. 15. 1454829–1454829. 4 indexed citations
9.
Elmorsy, Elsayed A., Sameh Saber, Rabab S. Hamad, et al.. (2024). Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib). Life Sciences. 354. 122966–122966. 7 indexed citations
10.
Elmorsy, Elsayed A., Rabab S. Hamad, Mustafa Ahmed Abdel‐Reheim, et al.. (2024). Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NFκB/NLRP3/IL-1β signaling in rats: Unraveling new roles beyond calcium channel blocking. International Immunopharmacology. 141. 113000–113000. 6 indexed citations
11.
Nasr, Mohamed, et al.. (2024). Localized delivery of Roxadustat via cubosomes-based thermosensitive in-situ hydrogel enhances diabetic wound healing by stabilizing HIF-1α in rats. Journal of Drug Delivery Science and Technology. 100. 106127–106127. 8 indexed citations
12.
Saber, Sameh, et al.. (2024). Silk fibroin/gelatin electrospun nanofibrous dressing loaded with roxadustat accelerates wound healing in diabetic rats via HIF-1α stabilization. Journal of Drug Delivery Science and Technology. 103. 106439–106439. 1 indexed citations
13.
Mohammed, Osama A., Ahmed S. Doghish, Rabab S. Hamad, et al.. (2024). Linagliptin, a DPP ‐4 inhibitor, activates AMPK / FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights. The FASEB Journal. 38(4). e23480–e23480. 5 indexed citations
14.
Elmorsy, Elsayed A., Sameh Saber, Rabab S. Hamad, et al.. (2024). Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies. European Journal of Pharmaceutical Sciences. 203. 106939–106939. 40 indexed citations
15.
16.
20.
Shata, Ahmed, Ahmed A. Shaaban, Sameh Saber, et al.. (2022). The Effects of Hyphaena thebaica and Lactobacillus in Dextran Sodium Sulphate-Induced Ulcerative Colitis in Rats. 5(2). 201–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026